This invention provides a compound having the formula: STR1 wherein R1 and R3 independently are hydrogen, --CHO, --COCH3, --COR7, --A--Ar--(Q)z, etc.; wherein D is a C1-6 linear, C3-8 branched or cyclic group having from 4 to about 15 atoms, consisting of C, etc.; wherein D is unsubstituted or substituted with one or more groups independently selected from the group consisting of --OH, NH2, --NHR7, etc.; wherein each Q is independently --CNH(NHY), --NHCNH(NHY), --SO2 W, --SOW, etc.; wherein Y is hydrogen, alkyl, alkenyl, --B--NH2, --B--NHR8, etc.; wherein W is alkyl, alkenyl, --B--NH2, etc.; wherein A nd B independently are a bond, or a C1-6 linear, C3-8 branched or cyclic linking group having from 1 to about 15 atoms, consisting of C, optionally interrupted by N, S, P and O; wherein A and B independently are unsubstituted or substituted with --OH, NH2, etc.; wherein R7 is an alkyl, a branched alkyl, etc.; wherein R8, R9, and R10 are independently represented by hydrogen, alkyl, branched alkyl, etc.; wherein x is 0, 1 or 2; and z is 0, 1, 2, or 4; wherein R1 ' and R3 ' are independently selected from the group consisting of hydrogen, alkyl and benzyl, or alternatively, R1 and R1 ' or R3 and R3 ' with their respective nitrogen atoms independently form a phthalimido, succinimido, etc.; wherein R4, R5, and R6 independently are selected from the group consisting of hydrogen, --CHO, --COCH3, --COR7, etc.; therein said saccharides are optionally linked at the one position of said saccharid group; wherein R4 and R5, or R5 and R6, together comprise a methylidene, ethylidene, isopropylident, cyclohexylidene or benzylidene bridge, or R3 and R4, or R1 and R6, together independently form an intramolecular carbamate; wherein R5 is not hydrogen or glycosyl when R3 and R4, or R1 and R6, together independently form an intramolecular carbamate; with the provisio that at least two of R1, R1 ', R3, R3 ', R4, R5, and R6 are not hydrogen. Also provided are pharmaceutical compositions comprising the compound and methods of inhibiting binding of human immunodeficiency virus REV protein to RRE.